Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
Authors:
- Madhukar PaiMPMadhukar Pai
- Dick MenziesDMDick Menzies
- T Mark DohertyTDT Mark Doherty
- Gerhard WalzlGWGerhard Walzl
- Mark D PerkinsMPMark D Perkins
- Alimuddin ZumlaAZAlimuddin Zumla
Top Cited Papers
- 1 May 2010
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 375 (9729) , 1920-1937
Abstract
No abstract availableKeywords
This publication has 172 references indexed in Scilit:
- Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnosticsProceedings of the National Academy of Sciences, 2009
- Drivers of tuberculosis epidemics: The role of risk factors and social determinantsSocial Science & Medicine, 2009
- Strain specificity of antimycobacterial immunity in whole blood culture after cure of tuberculosisTuberculosis, 2009
- Averting epidemics of extensively drug-resistant tuberculosisProceedings of the National Academy of Sciences, 2009
- Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trialThe Lancet, 2009
- Development and Validation of a Protein-based Signature for the Detection of Ovarian CancerClinics In Laboratory Medicine, 2009
- Impact of enhanced tuberculosis diagnosis in South Africa: A mathematical model of expanded culture and drug susceptibility testingProceedings of the National Academy of Sciences, 2008
- Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania majorNature Medicine, 2007
- Reducing the global burden of tuberculosis: the contribution of improved diagnosticsNature, 2006
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001